Projects funded by the NCN

Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

The use of genetic tools in experimental therapy of polyglutamine diseases.

2015/18/E/NZ2/00678

Keywords:

RNAi shRNA CRISPR/Cas9 HD SCA3

Descriptors:

  • NZ2_1: Molecular genetics
  • NZ5_7: Human disease treatment
  • NZ1_1: Molecular biology

Panel:

NZ2 - Genetics, genomics: molecular genetics, genomics, proteomics, bioinformatics, systems biology, genetic epidemiology

Host institution :

Instytut Chemii Bioorganicznej PAN

woj. wielkopolskie

Other projects carried out by the institution 

Principal investigator (from the host institution):

dr hab. Marta Olejniczak 

Number of co-investigators in the project: 4

Call: SONATA BIS 5 - announced on 2015-06-15

Amount awarded: 1 917 600 PLN

Project start date (Y-m-d): 2016-04-18

Project end date (Y-m-d): 2021-10-17

Project duration:: 66 months (the same as in the proposal)

Project status: Project settled

Project description

Download the project description in a pdf file

Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

Equipment purchased [PL]

  1. aparat do elektroforezy i transferu białek z zasilaczem (30 000 PLN)
  2. zestaw adaptujący wieszak MTP do rotora wirówki.
  3. aparat do elektroforezy westem blot dedykowany do rozdzialu bialek w komercyjnych żelach gradientowych.
  4. licznik komórek (15 000 PLN)
  5. zestaw komputerowy wraz z oprogramowaniem (2 szt.) (9 000 PLN)
  6. Inkubator bakteryjny z wyposażeniem.
  7. termocykler (30 000 PLN)

Information in the final report

  • Publication in academic press/journals (9)
  • Articles in post-conference publications (2)
  • Book publications / chapters in book publications (1)
  1. Generation of new isogenic models of Huntington's disease using CRISPR-Cas9 technology
    Authors:
    Dabrowska M, Ciolak A, Kozlowska E, Fiszer A. and Olejniczak M
    Academic press:
    International Journal of Molecular Sciences (rok: 2020, tom: 21(5), strony: 1854), Wydawca: MDPI
    Status:
    Published
    DOI:
    10.3390/ijms21051854 - link to the publication
  2. Paving the way towards precise and safe CRISPR genome editing
    Authors:
    Pawel Sledzinski, Magdalena Dabrowska, Mateusz Nowaczyk, Marta Olejniczak
    Academic press:
    Biotechnology Advances (rok: 2021, tom: 49, strony: 45311), Wydawca: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.biotechadv.2021.107737 - link to the publication
  3. Stress-induced changes in miRNA biogenesis and functioning
    Authors:
    Olejniczak M, Kotowska-Zimmer A, Krzyzosiak WJ
    Academic press:
    Cell Mol Life Sci., (rok: 2018, tom: 75, strony: 177-191), Wydawca: Springer
    Status:
    Published
    DOI:
    10.1007/s00018-017-2591-0 - link to the publication
  4. A CAG repeat-targeting artificial miRNA lowers the mutant huntingtin level in the YAC128 model of Huntington's disease
    Authors:
    Kotowska-Zimmer A., Przybyl L., Pewinska M., Suszynska-Zajczyk J., Wronka D., Figiel M. and Olejniczak M
    Academic press:
    Molecular Therapy Nucleic Acids (rok: 2022, ), Wydawca: Cell Press
    Status:
    Accepted for publication
    DOI:
    brak - link to the publication
  5. Artificial miRNAs as therapeutic tools: challenges and opportunities
    Authors:
    Kotowska-Zimmer A, Pewinska M, Olejniczak M
    Academic press:
    WIREs RNA (rok: 2021, tom: nie dotyczy, strony: nie dotyczy), Wydawca: Wiley Periodicals LLC
    Status:
    Published
    DOI:
    10.1002/wrna.1640 - link to the publication
  6. Generation of human iPS cell line IBCHi001-A from dentatorubral-pallidoluysian atrophy patient's fibroblasts
    Authors:
    Kozlowska E, Ciolak A, Olejniczak M, Fiszer A.
    Academic press:
    Stem Cell Research (rok: 2019, tom: 39, strony: 101512), Wydawca: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.scr.2019.101512 - link to the publication
  7. qEva-CRISPR: a method for quantitative evaluation of CRISPR/Cas-mediated genome editing in target and off-target sites
    Authors:
    Dabrowska M, Czubak K, Juzwa W, Krzyzosiak WJ, Olejniczak M, Kozlowski P
    Academic press:
    Nucleic Acids Res (rok: 2018, tom: 46(17), strony: e101), Wydawca: Oxford Academic
    Status:
    Published
    DOI:
    10.1093/nar/gky505 - link to the publication
  8. Precise excision of the CAG tract from the Huntingtin Gene by Cas9 Nickases
    Authors:
    Dabrowska M, Juzwa W, Krzyzosiak WJ, Olejniczak M
    Academic press:
    Front Neurosci (rok: 2018, tom: 0,552083333333333, strony: 45299), Wydawca: Frontiers Media SA
    Status:
    Published
    DOI:
    10.3389/fnins.2018.00075 - link to the publication
  9. Universal RNAi Triggers for the Specific Inhibition of Mutant Huntingtin, Atrophin-1, Ataxin-3, and Ataxin-7 Expression
    Authors:
    Kotowska-Zimmer A, Ostrovska Y, Olejniczak M
    Academic press:
    Mol Ther Nucleic Acids (rok: 2020, tom: 19, strony: 562-571), Wydawca: CellPress
    Status:
    Published
    DOI:
    10.1016/j.omtn.2019.12.012 - link to the publication
  1. A CAG repeat-targeting artificial miRNA lowers the mutant huntingtin level in the YAC128 model of Huntington's disease
    Authors:
    M. Olejniczak, A. Kotowska-Zimmer, L. Przybyl, M. Pewińska, J. Suszynska-Zajczyk, D. Wronka, M. Figiel
    Conference:
    European Huntington's Disease Network (EHDN) Meeting (rok: 2021, ), Wydawca: BMJ Journals
    Data:
    konferencja 9-11.09
    Status:
    Published
  2. Universal RNAi triggers for specific inhibition of mutant huntingtin, ataxin-3, ataxin-7 and atrophin-1 expression
    Authors:
    A. Kotowska-Zimmer, J. Ostrowska, K. Grochowina, A. Ciesiołka, P. Joachimiak, A. Fiszer, M. Olejniczak
    Conference:
    the 44th FEBS Congress (rok: 2019, ), Wydawca: FEBS Open Bio
    Data:
    konferencja 6-11.07.2019
    Status:
    Published
  1. Gene Therapy for Huntington's Disease Using Targeted Endonucleases
    Authors:
    Magdalena Dabrowska and Marta Olejniczak
    Book:
    Methods in Molecular Biology, Trinucleotide repeats (rok: 2020, tom: 2056, strony: 269-284), Wydawca: Humana Press
    Status:
    Published

O Narodowym Centrum Nauki

Finansowanie nauki

Współpraca zagraniczna

Centrum prasowe

Deklaracja dostępności
Przetwarzanie danych osobowych
Polityka cookies

Partnerzy